How to deal with drug resistance while taking filgotinib

When patients experience decreased efficacy or rebound of disease symptoms while taking filgotinib for a long time, it is likely to be due to the development of drug tolerance or weakened response to the drug's efficacy. As targeted therapeutic drugs, JAK inhibitors have complex resistance mechanisms, which may involve reactivation of cytokine pathways, mutations in downstream signaling molecules, changes in the patient's immune environment, and even factors related to individual metabolism. Faced with this situation, it is particularly important to adopt reasonable response strategies.

First of all, patients should avoid stopping the drug or changing the dose on their own. Once they find that the efficacy is not as good as expected, they should immediately communicate with the attending physician to evaluate whether it is true drug resistance or other factors leading to a decrease in drug efficacy. Doctors usually first use disease assessment tools (such asDAS28 score), imaging examinations and laboratory indicators to determine whether the drug is still functioning as it should.

If drug resistance or poor efficacy is diagnosed, the first step is usually to consider changing the treatment regimen. Currently, in addition to filgotinib, there are several other JAK inhibitors with different mechanisms (such as tofacitinib, upadatinib, baricitinib). Their selectivity among JAK1, JAK2 and JAK3 is different, and switching may bring new therapeutic responses. If the disease still cannot be controlled by replacing similar drugs, doctors may also consider switching to biological agents with other targets such as TNF-α inhibitors, IL-6 inhibitors, and B cell monoclonal antibodies.

Secondly, in order to avoid the emergence of single mechanism resistance, combination treatment strategies are sometimes used, such as combining filgotinib with traditional DMARDs (such as methotrexate) to enhance the anti-inflammatory effect and delay the occurrence of resistance. In addition, appropriate lifestyle intervention cannot be ignored, such as reasonable diet, weight control, and strengthening exercise management. These factors will also affect the overall activity of the immune system and indirectly promote the efficacy of the drug.

Reference materials:https://go.drugbank.com/drugs/DB14845